Puma Biotechnology, Inc.
PBYI
$2.95
-$0.055-1.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 57.36% | 250.53% | -313.03% | -443.68% | 318.84% |
| Total Depreciation and Amortization | -1.66% | 0.07% | 1.11% | 0.66% | 17.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.63% | -36.72% | -36.22% | -12.37% | -70.93% |
| Change in Net Operating Assets | -5.23% | -1,054.28% | 116.53% | 338.65% | -720.94% |
| Cash from Operations | 49.28% | 3.98% | -68.84% | 325.50% | 36.08% |
| Capital Expenditure | 64.44% | 25.93% | 70.59% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.64% | -97.51% | 115.67% | -9.34% | 31.57% |
| Cash from Investing | 71.60% | -97.68% | 115.01% | -9.34% | 31.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.40% | -99.48% | -592.29% | 47.09% | 229.90% |